IL6 and breast carcinoma: Interestingly, disordered hepcidin/ferroportin activity have been shown to promote growth of breast cancer cells, with elevated ferroportin expression responsible for inhibition of proliferation; importantly IL-6 was also shown to promote proliferation of these cells23, supporting the above concept.